2006 PRESS RELEASES

OxyPharma Appoints POI as CRO
for Phase II RA Drug Study

POI Opens Office in South Africa

POI Expands Data Management
and Biostatistic Services

POI Announces Expansion
of Indian Operations

POI Awarded New Trials in Lung
Cancer, Rheumatoid Arthritis, and
Thromboembolism

POI Adds Additional Offices
in Latin America

POI Adds Business Development
Staff with Clinical Experience

POI Announces $13.4 Million in
Contracts for Clinical Services

BACK TO PRESS RELEASES